Search - tctmd.com

Displaying 41 - 60 of 204

Sort: Relevancy | Date

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

News Conference News ACC 2023

Tailored Alerts Up High-Intensity Statin Prescribing: PCDS Statin

Yael L. Maxwell

March 13, 2023

News Conference News ACC 2023

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Michael O'Riordan

March 09, 2023

News Daily News

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Michael O'Riordan

February 22, 2023

News Daily News

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

L.A. McKeown

February 13, 2023

News Conference News ISC 2023

Cilostazol, Isosorbide Mononitrate May Help After Lacunar Stroke: LACI-2

Todd Neale

February 10, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Michael O'Riordan

January 12, 2023

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

Todd Neale

November 23, 2022

News Conference News AHA 2022

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Todd Neale

November 10, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Michael O'Riordan

August 28, 2022

Advertisement

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

Tailored Alerts Up High-Intensity Statin Prescribing: PCDS Statin

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

Cilostazol, Isosorbide Mononitrate May Help After Lacunar Stroke: LACI-2

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

CV Care Around Noncardiac Surgery: New ESC Guidelines

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content